210 related articles for article (PubMed ID: 10942602)
1. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
3. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
4. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
[TBL] [Abstract][Full Text] [Related]
5. Role of proteasomes in T cell activation and proliferation.
Wang X; Luo H; Chen H; Duguid W; Wu J
J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
[TBL] [Abstract][Full Text] [Related]
6. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
Nguyen H; Gitig DM; Koff A
Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
Zhang F; Mönkkönen M; Roth S; Laiho M
Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
[TBL] [Abstract][Full Text] [Related]
8. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.
Kitzmann M; Vandromme M; Schaeffer V; Carnac G; Labbé JC; Lamb N; Fernandez A
Mol Cell Biol; 1999 Apr; 19(4):3167-76. PubMed ID: 10082583
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
11. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
[TBL] [Abstract][Full Text] [Related]
12. Cdc2-cyclin E complexes regulate the G1/S phase transition.
Aleem E; Kiyokawa H; Kaldis P
Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
Zariwala M; Liu J; Xiong Y
Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
Taipale M; Tiihonen E; Heiskanen A; Laiho M
Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
[TBL] [Abstract][Full Text] [Related]
16. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
[TBL] [Abstract][Full Text] [Related]
17. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
Puri PL; Balsano C; Burgio VL; Chirillo P; Natoli G; Ricci L; Mattei E; Graessmann A; Levrero M
Oncogene; 1997 Mar; 14(10):1171-84. PubMed ID: 9121766
[TBL] [Abstract][Full Text] [Related]
18. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).
Tedesco D; Lukas J; Reed SI
Genes Dev; 2002 Nov; 16(22):2946-57. PubMed ID: 12435635
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
20. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
